SCHEMBL721340

SCHEMBL721340

CCCCCC(N)NC(N)CCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.55
SPHK1 Q9NYA1 2/20 0.44
TP53 P04637 2/20 0.43
LAP3 P28838 2/20 0.43
CYP2D6 P10635 2/20 0.41
LMNA P02545 2/20 0.41
PLA2G1B P04054 1/20 0.41
PLA2G2A P14555 1/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
CETP P11597 1/20 0.41
HTT P42858 1/20 0.41
UBE2N P61088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5702825 0.97 OPRM1 (0.52) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL2026328 0.92 OPRM1 (0.43) OPRM1SPHK1TP53LAP3CYP3A4
SCHEMBL10751730 0.87 OPRM1 (0.54) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL29007339 0.87 OPRM1 (0.54) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL28004000 0.84 OPRM1 (0.50) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL4583584 0.84 SPHK1 (0.52) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL11034807 0.82 OPRM1 (0.43) OPRM1SPHK1TP53LAP3CYP2D6
SCHEMBL18315351 0.81
SCHEMBL2024922 0.79 OPRM1 (0.35) OPRM1GRIK1SLC1A2SLC1A1GRIK2
SCHEMBL11155476 0.79 OPRM1 (0.50) OPRM1SPHK1TP53LAP3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009027186-A2 HYPERBRANCHED POLYMERS COMPRISING GUANIDINE UNITS BASF SE (DE) 2009-03-05 WO claimed
US-20080306237-A1 Highly Functional, Highly Branched Polyureas BASF AKTIENGESELLSCHAFT (DE) 2008-12-11 US claimed
EP-1716197-B1 HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS BASF SE (DE) 2008-10-29 EP claimed
EP-1716197-A1 HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS BASF AKTIENGESELLSCHAFT (DE) 2006-11-02 EP claimed
WO-2005075541-A1 HIGHLY FUNCTIONAL, HIGHLY BRANCHED POLYUREAS BASF AKTIENGESELLSCHAFT (DE) 2005-08-18 WO claimed
EP-4072289-A1 SUSPENSION CONCENTRATE BASF Agro B.V. (NL) 2022-10-19 EP disclosed
EP-2032115-B1 COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS DSM IP ASSETS BV (NL) 2021-07-21 EP disclosed
WO-2021115916-A1 SUSPENSION CONCENTRATE BASF Agro B.V. (NL) 2021-06-17 WO disclosed
US-10316131-B2 Hyperbranched polymer modified with isocyanate linker and mix of short and long chain alkyl polyether BASF SE (DE) 2019-06-11 US disclosed
EP-3237498-B1 HYPERBRANCHED POLYMER MODIFIED WITH ISOCYANATE LINKER AND MIX OF SHORT AND LONG CHAIN ALKYL POLYETHER BASF SE (DE) 2019-02-20 EP disclosed
EP-1991604-B1 NOVEL HETEROCYCLIC SUBSTITUTED CONDENSATION POLYMERS DSM IP ASSETS BV (NL) 2018-03-28 EP disclosed
US-20170327621-A1 HYPERBRANCHED POLYMER MODIFIED WITH ISOCYANATE LINKER AND MIX OF SHORT AND LONG CHAIN ALKYL POLYETHER BASF SE (DE) 2017-11-16 US disclosed
WO-2004037881-A1 USE OF HYPERBRANCHED POLYMERS COMPRISING URETHANE AND/OR UREA GROUPS FOR MODIFYING SURFACES BASF AKTIENGESELLSCHAFT (DE) 2004-05-06 WO disclosed
US-6730771-B2 THERMOPLASTIC, THERMOSETTING RESINS DSM N.V. (NL) 2004-05-04 US disclosed
EP-1171510-B1 CONDENSATION POLYMER CONTAINING DIALKYLAMIDE ENDGROUPS, PROCESS FOR PRODUCING SAID CONDENSATION POLYMERS AND APPLICATIONS THEREOF DSM IP ASSETS BV (NL) 2003-11-05 EP disclosed
US-6541110-B2 Endcapped polyamideester copolymers; compatible blend with another polymer DSM N.V. (NL) 2003-04-01 US disclosed
WO-2002085841-A2 SUBSTITUTED CATECHOL DERIVATIVES DERIVED FROM POLYBASIC SECONDARY AMINO ACIDS, METHOD FOR PRODUCTION AND USE THEREOF Grünenthal GmbH (DE) 2002-10-31 WO disclosed
US-20020137880-A1 Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof DSM IP ASSETS B.V. (NL) 2002-09-26 US disclosed
US-20020019509-A1 Condensation polymer containing dialkylamide endgroups, process for producing said condensation polymers and applications thereof DSM N.V. (NL) 2002-02-14 US disclosed
EP-1038902-A1 Condensation polymers containing dialkylamide endgroups, process for their production and applications thereof DSM N.V. (NL) 2000-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10316131-B2 Hyperbranched polymer modified with isocyanate linker and mix of short and long chain alkyl polyether ATL3, HACD3, GHDC OPRM1 4574/4885SPHK1 2233/4885TP53 4040/4885
US-20170327621-A1 HYPERBRANCHED POLYMER MODIFIED WITH ISOCYANATE LINKER AND MIX OF SHORT AND LONG CHAIN ALKYL POLYETHER ATL3, HACD3, GHDC OPRM1 4574/4885SPHK1 2233/4885TP53 4040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.